Johnson & Johnson MedTech, formerly known as DePuy Synthes, will hold its 33rd annual craft bazaar Saturday, Oct. 25.

Johnson & Johnson’s plans to spin off its orthopedics business is underway, and the move is expected to, leaders said in its third quarter 2025 earnings call. “We continue to invest at industry ...

J&J CEO Joaquin Duato told investors this week that the orthopedics spinoff would allow J&J to focus on faster-growing ...

Johnson & Johnson raised its 2025 revenue guidance as Stelara erosion slowed, while BofA maintained a Neutral rating citing fair valuation.

Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business.

Johnson and Johnson is the latest medtech company to announce plans to segment its orthopedic business into its own company. It is the latest in a recent trend of medtech companies parting ways with ...

Breaking up isn’t so hard to do, after all. Just two years after spinning off its consumer products as Kenvue Inc., Johnson & Johnson aims to part ways with its orthopedics unit, which will take with ...

Johnson & Johnson said Tuesday it will spin off its orthopedics business into a new company called DePuy Synthes.

(Reuters) -Johnson & Johnson said on Tuesday it plans to separate its orthopedics business into a standalone company named ...

Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business.

Johnson & Johnson raises 2025 sales forecast and beats quarterly estimates, while announcing plans to spin off its $9.2 billion orthopedics business.

Staff at the Cork branch of Johnson & Johnson's orthopaedics subsidiary DePuy Synthes have been informed of its parent company's intent to separate it into a standalone business. The healthcare giant ...